tiprankstipranks
Can-Fite BioPharma (CANF)
XASE:CANF
US Market
CANF
Can-Fite BioPharma
RESEARCH TOOLSreports
Want to see CANF full AI Analyst Report?

Can-Fite BioPharma (CANF) Stock News & Sentiment

655 Followers
Can-Fite and Vetbiolix Gain Peer-Reviewed Validation for Piclidenoson in Canine Osteoarthritis
Premium
Company Announcements
Can-Fite and Vetbiolix Gain Peer-Reviewed Validation for Piclidenoson in Canine Osteoarthritis
2d ago
6K
CANF
Can-Fite to Advance Namodenoson into Phase 2b Pancreatic Cancer Combo Trial After Positive Data
Premium
Company Announcements
Can-Fite to Advance Namodenoson into Phase 2b Pancreatic Cancer Combo Trial After Positive Data
7d ago
6K
CANF
Can-Fite Posts Positive Phase 2a Results for Namodenoson in Advanced Pancreatic Cancer
Premium
Company Announcements
Can-Fite Posts Positive Phase 2a Results for Namodenoson in Advanced Pancreatic Cancer
20d ago
6K
CANF
Can-Fite BioPharma Sets May 28, 2026 AGM to Vote on Share Capital Increase and Executive Option Grants
Premium
Company Announcements
Can-Fite BioPharma Sets May 28, 2026 AGM to Vote on Share Capital Increase and Executive Option Grants
27d ago
6K
CANF
Can-Fite and Vetbiolix Complete Phase 2 Enrollment for Canine Osteoarthritis Drug Piclidenoson
Premium
Company Announcements
Can-Fite and Vetbiolix Complete Phase 2 Enrollment for Canine Osteoarthritis Drug Piclidenoson
2M ago
6K
CANF
Can-Fite BioPharma Posts 2025 Loss but Highlights Long-Term Cancer Survival and Clinical Progress
Premium
Company Announcements
Can-Fite BioPharma Posts 2025 Loss but Highlights Long-Term Cancer Survival and Clinical Progress
2M ago
6K
CANF
CANF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CANF Upcoming Earnings Report: What to Expect?
2M ago
CANF
More CANF News >

CANF News on the Web

Can-Fite and Vetbiolix Gain Peer-Reviewed Validation for Piclidenoson in Canine Osteoarthritis
TipRanks News
Neutral
Can-Fite BioPharma upgraded to Buy from Hold at D. Boral Capital
TipRanks News
Bullish
Can-Fite to Advance Namodenoson into Phase 2b Pancreatic Cancer Combo Trial After Positive Data
TipRanks News
Neutral
Can-Fite BioPharma target adjusted to $5 from $2.50 at H.C. Wainwright
TipRanks News
Bullish
Can-Fite Posts Positive Phase 2a Results for Namodenoson in Advanced Pancreatic Cancer
TipRanks News
Neutral
Can-Fite’s Phase 2a Pancreatic Cancer Data Shows 35% of Patients Remain on Namodenoson Therapy, One for Over 16 Months
Market Chameleon
Bullish
Can-Fite BioPharma Sets May 28, 2026 AGM to Vote on Share Capital Increase and Executive Option Grants
TipRanks News
Neutral
Can-Fite BioPharma files to sell 3.29M ordinary shares for holders
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
CANF
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CANF’s Media Buzz Sentiment?
1 articles about CANF were published this week. In an average week, 1.5 articles are published.
    What is CANF’s weekly average amount of articles?
    In an average week, 1.5 articles about CANF are published.
      What is CANF’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      DOCSDoximity
      AVAHAveanna Healthcare Holdings
      GOSSGossamer Bio
      CGENCompugen
      RLAYRelay Therapeutics
      Showing the stocks with the most bullish news sentiment over the past week